Diamond Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
April 26, 2022
Share
Diamond Biotechnology Co., Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 395.2 million compared to TWD 306.39 million a year ago. Net income was TWD 41.92 million compared to TWD 11.05 million a year ago. Basic earnings per share from continuing operations was TWD 1.96 compared to TWD 0.53 a year ago. Diluted earnings per share from continuing operations was TWD 1.96 compared to TWD 0.53 a year ago. Basic earnings per share was TWD 1.96 compared to TWD 0.53 a year ago. Diluted earnings per share was TWD 1.96 compared to TWD 0.53 a year ago.
Diamond Biotechnology Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of skin care products and medical equipment. The main products are skin care products and medical equipment. The skin care products include facial masks, lotions, creams, essences and others, which are mainly used for facial skin care and cleaning. The medical equipment includes wires, sonic wave medical equipment, radio wave medical equipment, frozen fat reduction medical equipment and other medical equipment, as well as micro plastic surgery consumables such as botulinum and collagen injections, which are mainly used to improve skin wrinkles and sagging. The Company is also engaged in the provision of medical equipment leasing services and medical beauty management consulting services. The Company operates within the domestic market and to overseas markets.
DIAMOND BIOTECHNOLOGY CO., LTD 
